Recent Blog Posts
-
Cash for Docs Startup Goes National
May 15 201211:42 am EDT -
Facebook Gets Into the Organ-Donation Game
May 01 201211:46 am EDT -
Don't Go to School High
Apr 04 201211:54 am EDT -
Drug Giants Look to Inject Startups
Mar 21 20124:56 pm EDT -
Former Drug Smuggler Pitches Legal Pot to Seniors
Mar 16 201210:50 am EDT -
Are Americans Smart About Eating Fish?
Feb 28 20122:47 pm EDT -
Medical Pot Goes Up in Smoke in Delaware, Fort Collins
Feb 13 20124:20 pm EDT -
"Wal-Mart" of Weed Welcomed to Washington
Jan 23 201210:57 am EDT -
Stick a Fork in This App, Paula Deen
Jan 20 20124:22 pm EDT -
Germ-Zapping Keyboard Approved for Hospitals
Jan 03 20124:32 pm EDT
AIDS Vaccine Was Overhyped
As it turns out, the big breakthrough in a study of an AIDS vaccine was a head fake.
The vaccine was only marginally effective, helping mostly people at low risk, according to an article in the New England Journal of Medicine.
Researchers involved in the human trial in Thailand, the biggest study of its kind, initially said two experimental vaccines showed promise for protecting against HIV infection. The vaccines are made by French drugmaker Sanofi-Aventis SA and VaxGen Inc., a small, struggling California biotech company.
Last month, the scientists said the vaccines appeared to reduce infections by 31 percent. Additional data from the trial published today didn't show the same effectiveness.
The new data illustrates the difficulty and frustration as scientists spend decades searching for an effective HIV treatment. A number of big companies are still studying AIDS vaccines and treatments, including Gillead Sciences Inc., Merck & Co., Johnson & Johnson, Bristol-Myers Squibb Co. and Abbott Laboratories. But success in finding an effective vaccine has been elusive.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
